Rentokil Initial (RTO) to Announce Earnings on Thursday

Rentokil Initial (NYSE:RTO) is anticipated to release its Q2 2026 resultson Thursday, July 30th. Analysts expect Rentokil Initial to post earnings of $0.66 per share and revenue of $3.5309 billion for the quarter. Individuals can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, July 30, 2026 at 2:00 AM ET.

Rentokil Initial Stock Down 0.5%

NYSE RTO opened at $29.86 on Thursday. Rentokil Initial has a 12 month low of $22.77 and a 12 month high of $34.67. The company’s 50 day simple moving average is $30.05 and its 200 day simple moving average is $31.38. The company has a current ratio of 1.16, a quick ratio of 1.07 and a debt-to-equity ratio of 0.76.

Hedge Funds Weigh In On Rentokil Initial

Institutional investors and hedge funds have recently bought and sold shares of the business. Elevation Point Wealth Partners LLC purchased a new position in Rentokil Initial in the fourth quarter valued at about $205,000. Sepio Capital LP purchased a new stake in shares of Rentokil Initial during the 4th quarter worth about $217,000. Vise Technologies Inc. acquired a new stake in shares of Rentokil Initial during the 4th quarter valued at about $224,000. Russell Investments Group Ltd. lifted its holdings in shares of Rentokil Initial by 35.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,225 shares of the company’s stock valued at $157,000 after buying an additional 1,643 shares during the last quarter. Finally, Osaic Holdings Inc. grew its stake in shares of Rentokil Initial by 38.9% in the 2nd quarter. Osaic Holdings Inc. now owns 8,886 shares of the company’s stock valued at $211,000 after buying an additional 2,490 shares in the last quarter. Hedge funds and other institutional investors own 9.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Zacks Research lowered shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Monday, June 15th. The Goldman Sachs Group raised Rentokil Initial from a “neutral” rating to a “buy” rating in a research note on Monday, July 6th. Weiss Ratings restated a “hold (c)” rating on shares of Rentokil Initial in a report on Wednesday, June 24th. Finally, Wall Street Zen cut Rentokil Initial from a “buy” rating to a “hold” rating in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Rentokil Initial has a consensus rating of “Moderate Buy” and an average price target of $34.50.

Rentokil Initial Company Profile

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.